López-Galindo M, Roques M. Biomarkers in oral squamous cell carcinoma: A systematic review. Med Oral Patol Oral Cir Bucal. 2026 Jan 1;31 (1):e82-e88.

doi:10.4317/medoral.27565

https://dx.doi.org/doi:10.4317/medoral.27565

1. Radaic A, Kamarajan P, Cho A, Wang S, Hung GC, Najarzadegan F, et al. Biological biomarkers of oral cancer. Periodontol 2000. 2024;96(1):250-280
https://doi.org/10.1111/prd.12542
PMid:38073011 PMCid:PMC11163022

2. Mohajertehran F, Farshbaf A, Kashafi A, Shahabinejad M, Ebrahimzade S, Javan-Rashid A, et al. Evaluation of CD4+ tumor-infiltrating lymphocyte association with some clinicopathological indices of oral squamous cell carcinoma. Dent Res J (Isfahan). 2022;19:86
https://doi.org/10.4103/1735-3327.359323
PMid:36426281

3. Blatt S, Krüger M, Ziebart T, Sagheb K, Schiegnitz E, Goetze E, et al. Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: A review of the literature. J Craniomaxillofac Surg. 2017;45(5):722-730
https://doi.org/10.1016/j.jcms.2017.01.033
PMid:28318929

4. Hurník P, Režnarová J, Chyra Z, Motyka O, Putnová BM, Čermáková Z, et al. Enhancing oral squamous cell carcinoma prediction: The prognostic power of the worst pattern of invasion and the limited impact of molecular resection margins. Front Oncol. 2023;13:1287650
https://doi.org/10.3389/fonc.2023.1287650
PMid:38188288 PMCid:PMC10766711

5. Gualtero DF, Suarez Castillo A. Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: A systematic review. Acta Odontol Scand. 2016;74(3):170-177
https://doi.org/10.3109/00016357.2015.1110249
PMid:26577643

6. Wang L, Jiang N, Lee Chen C. Correlation between human papillomavirus protein expression and clinicopathological features in oral squamous cell carcinoma. Int J Immunopathol Pharmacol. 2024;38:3946320241272527
https://doi.org/10.1177/03946320241272527
PMid:39137056 PMCid:PMC11322946

7. Yu B, Cao W, Zhang C, Xia R, Liu J, Yan M, et al. Prediction of lymph node metastasis in oral squamous cell carcinoma based on protein profile. Expert Rev Proteomics. 2019;16(4):363-373
https://doi.org/10.1080/14789450.2019.1584039
PMid:30779878

8. Dunkel J, Vaittinen S, Grénman R, Kinnunen I, Irjala H. Prognostic markers in stage I oral cavity squamous cell carcinoma. Laryngoscope. 2013;123(10):2435-2441
https://doi.org/10.1002/lary.23888
PMid:23918741

9. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097
https://doi.org/10.1371/journal.pmed.1000097
PMid:19621072 PMCid:PMC2707599

10. Gadbail AR, Sarode SC, Chaudhary MS, Gondivkar SM, Tekade SA, Yuwanati M, et al. Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma. J Appl Oral Sci. 2021;29:e20200751
https://doi.org/10.1590/1678-7757-2020-0751
PMid:33656066 PMCid:PMC7934280

11. Zhou Y, Tang Y, Luo J, Yang Y, Zang H, Ma J, et al. High expression of HSP60 and survivin predicts poor prognosis for oral squamous cell carcinoma patients. BMC Oral Health. 2023;23:629
https://doi.org/10.1186/s12903-023-03311-5
PMid:37661276 PMCid:PMC10476324

12. Shabbir A, Waheed H, Ahmed S, Shaikh SS, Farooqui WA. Association of salivary Cathepsin B in different histological grades among patients presenting with oral squamous cell carcinoma. BMC Oral Health. 2022;22:63
https://doi.org/10.1186/s12903-022-02052-1
PMid:35260133 PMCid:PMC8905853

13. Maruse Y, Kawano S, Jinno T, Matsubara R, Goto Y, Kaneko N, et al. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47(7):836-845
https://doi.org/10.1016/j.ijom.2018.01.004
PMid:29395669

14. López-Verdín S, Martínez-Fierro ML, Garza-Veloz I, Zamora-Perez A, Grajeda-Cruz J, González-González R, et al. E-Cadherin gene expression in oral cancer: Clinical and prospective data. Med Oral Patol Oral Cir Bucal. 2019;24(4):e444-e451
https://doi.org/10.4317/medoral.23029
PMid:31256188 PMCid:PMC6667017

15. Vadla P, Deepthi G, Julakanti V, Jahagirdar D, Meruva S, Tantravahi S. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression. J Contemp Dent Pract. 2022;23(5):497-502
https://doi.org/10.5005/jp-journals-10024-3342
PMid:35986456

16. Segura IG, Secchi DG, Galíndez MF, Carrica A, Bologna-Molina R, Brunotto M, et al. Connexin 43, Bcl-2, Bax, Ki67, and E-cadherin patterns in oral squamous cell carcinoma and its relationship with GJA1 rs12197797 C/G. Med Oral Patol Oral Cir Bucal. 2022;27(4):e366-e374
https://doi.org/10.4317/medoral.25298
PMid:35717615 PMCid:PMC9271350

17. Drotárová Z, Rabajdová M, Mareková M, Kizek P, Vašková J. Considering SOD and miRNA analysis as potential prognostic markers in white lesion malignant transformation: A report of two cases. Medicine (Baltimore). 2024;103: e40928
https://doi.org/10.1097/MD.0000000000040928
PMid:39686488 PMCid:PMC11651523

18. Mota de Oliveira M, Peterle GT, Monteiro da Silva Couto CV, de Lima Maia L, Kühl A, Gasparini Dos Santos J, et al. PAI-1 expression in intratumoral inflammatory infiltrate contributes to lymph node metastasis in oral cancer: A cross-sectional study. Ann Med Surg (Lond). 2021;65:102303
https://doi.org/10.1016/j.amsu.2021.102303
PMid:34094525 PMCid:PMC8167432

19. Kujan O, Huang G, Ravindran A, Vijayan M, Farah CS. The role of cyclin-dependent kinases in oral potentially malignant disorders and oral squamous cell carcinoma. J Oral Pathol Med. 2019;48(7):560-565
https://doi.org/10.1111/jop.12903
PMid:31172620

20. Piersiala K, Farrajota Neves da Silva P, Hjalmarsson E, Kolev A, Kågedal Å, Starkhammar M, et al. CD4+ and CD8+ T cells in sentinel nodes exhibit distinct pattern of PD-1, CD69, and HLA-DR expression compared to tumor tissue in oral squamous cell carcinoma. Cancer Sci. 2021;112(3):1048-1059
https://doi.org/10.1111/cas.14816
PMid:33462898 PMCid:PMC7935788

21. Feng Y, Li Q, Chen J, Yi P, Xu X, Fan Y, et al. Salivary protease spectrum biomarkers of oral cancer. Int J Oral Sci. 2019;11:7
https://doi.org/10.1038/s41368-018-0032-z
PMid:30602733 PMCid:PMC6315043

22. Feitosa SG, Viana KF, Luna ECM, Costa FWG, Cavalcante RB, Chaves FN, et al. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev. 2018;19(7):1779-1783
https://doi.org/10.22034/APJCP.2018.19.7.1779
PMid:30049187

23. Decker JML, de Oliveira Filho OV, Freitas MO, de Lima Silva-Fernandes IJ, Dantas TS, de Paula Campêlo CS, et al. PMS2: A potential prognostic protein marker in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2020;26(4):e451
https://doi.org/10.4317/medoral.24303
PMid:33247565 PMCid:PMC8254887

24. Zhou P, Xiao L, Xu X. Identification of E2F transcription factor 7 as a novel potential biomarker for oral squamous cell carcinoma. Head Face Med. 2021;17:7
https://doi.org/10.1186/s13005-021-00258-2
PMid:33637098 PMCid:PMC7908640

25. Domingueti CB, Castilho DAQ, de Oliveira CE, Janini JBM, González-Arriagada WA, Salo T, et al. Eukaryotic translation elongation factor 1δ, N-terminal propeptide of type I collagen and cancer-associated fibroblasts are prognostic markers of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(6):700-707.e2
https://doi.org/10.1016/j.oooo.2020.09.003
PMid:33132084

26. Ju WT, Xia RH, Zhu DW, Dou SJ, Zhu GP, Dong MJ, et al. A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nat Commun. 2022;13:5378
https://doi.org/10.1038/s41467-022-33080-8
PMid:36104359 PMCid:PMC9472189

27. Chen PK, Hua CH, Hsu HT, Kuo TM, Chung CM, Lee CP, Tsai MH, et al. ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients. Am J Pathol. 2019;189(1):190-199
https://doi.org/10.1016/j.ajpath.2018.09.003
PMid:30315765

28. Abdel Fattah Tarrad N, Gamil Shaker O, Abdelkawy M, Hassan S. Association of serum and salivary dipeptidyl peptidase-4 (DPP-4) with oral cancerous and precancerous lesions; an observational diagnostic accuracy study. BMC Oral Health. 2024;24:1206
https://doi.org/10.1186/s12903-024-04939-7
PMid:39390508 PMCid:PMC11468375

29. Nayak S, Bhatt MLB, Goel MM, Gupta S, Mahdi AA, Mishra A, Mehrotra D. Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy. PLoS One. 2018;13(6):e0199665
https://doi.org/10.1371/journal.pone.0199665
PMid:29953521 PMCid:PMC6023195

30. Ramalingam S, Shantha S, Srinivasan CP, Priyathersini N, Muralitharan S, Sudhakar U, et al. Expression of mTOR, CD163, α-SMA, FOXp3 as survival predictors and its significance in patients with oral squamous cell carcinoma. BMC Oral Health. 2024;24:1487
https://doi.org/10.1186/s12903-024-05245-y
PMid:39695576 PMCid:PMC11653707

31. Shen S, Zhang H, Qian Y, Zhou X, Li J, Zhang L, et al. Prognostic Analysis of Lactic Acid Metabolism Genes in Oral Squamous Cell Carcinoma. Int Dent J. 2024;74(5):1053-1063
https://doi.org/10.1016/j.identj.2024.04.005
PMid:38677972 PMCid:PMC11561504

32. Wu CL, Huang CC, Wu SY, Jiang SS, Tsai FY, Hsiao JR. A new scoring system facilitating diagnosis of oral squamous malignancy on biopsy specimens. BMC Oral Health. 2022;22:165
https://doi.org/10.1186/s12903-022-02188-0
PMid:35524231 PMCid:PMC9074340

33. Sakurai S, Ishida Y, Shintani T, Yamasaki S, Matsui K, Hamana T, et al. Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study. Pathol Oncol Res. 2024;30:1611571
https://doi.org/10.3389/pore.2024.1611571
PMid:38312516 PMCid:PMC10830843